Physician

Alan Andrew Macgill, DPM

According to 2025 Medicare claims, Alan Macgill, DPM (NPI: 1225270416) practices podiatry in the West Palm Beach-Boca Raton-Delray Beach, FL market, with the plurality of this provider's patient population coming from Palm Beach, FL. This provider's primary affiliated billing organization is NEUROSPINE INSTITUTE LLC (NPI: 1710306774; TIN: 46-5318844) and primary practice location at 33434-3988.

Macgill's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 243 traditional Medicare patients, billed 785 HCPCS/CPT codes, and received $66,376 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 161 prescription claims across 98 beneficiaries totaling $1,283 in drug costs, led by Celecoxib (Celecoxib). 2020 DME data shows 11 claims. Open Payments data shows 56 records totaling $14,622. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing started with an early spike, then settled into a lower baseline, moving from $195,745 to $66,376. Similarly, Part D prescription costs have declined steadily, from $15,486 to $1,283. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $8,927 to $98.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	578	3,421	$195,745
2016	547	2,980	$174,838
2017	376	1,722	$103,628
2018	182	791	$58,508
2019	309	1,230	$97,403
2020	215	1,045	$77,338
2021	265	1,054	$83,215
2022	244	936	$69,597
2023	261	923	$70,554
2024	243	785	$66,376

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	127	256	$15,486
2016	102	177	$11,194
2017	57	106	$16,575
2018	68	110	$5,909
2019	83	158	$3,860
2020	61	119	$1,992
2021	87	158	$2,352
2022	96	191	$2,329
2023	101	183	$1,421
2024	98	161	$1,283

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	70	71	$7,721
2016	90	92	$10,224
2017	29	29	$3,822
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	11	$98
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	81	81	$122
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	85	121	$95
99203	New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more	51	51	$80
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	107	180	$63
73630	X-ray of foot, minimum of 3 views	70	89	$31

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Celecoxib	Celecoxib	12	390	$231
Tramadol Hcl	Tramadol Hcl	32	171	$152
Gabapentin	Gabapentin	22	730	$146
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	18	71	$103
Methylprednisolone	Methylprednisolone	17	114	$87

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	56	$14,622	Arthrex, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Alan Andrew Macgill, DPM?

Tedicare shows public-source Medicare data for Alan Andrew Macgill, DPM (NPI 1225270416), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Alan Andrew Macgill, DPM have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Alan Andrew Macgill, DPM?

Alan Andrew Macgill, DPM is linked to NEUROSPINE INSTITUTE LLC (billing NPI 1710306774) in the available physician profile data.

Does Alan Andrew Macgill, DPM have Open Payments data?

Alan Andrew Macgill, DPM has 56 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.